logo

For the Inventor, By the Inventor

Cheshire, CT, United States of America

Clark Norman Eid

This inventor holds 5 USPTO granted patents. Top assignees: Eli Lilly and Company, Elan Pharmaceuticals, Inc., Athena Neurosciences, Inc.. Active years: 2000-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Clark Norman Eid. Retrieved from https://idiyas.com/inventor/clark-norman-eid

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5

% Patents Active = 60.0

Average Co-Inventor Count = 10.6

ph-index = 2

Forward Citations = 46(Granted Patents)


Company Filing History:

goldMedal3 out of 4,517 
 
Eli Lilly and Company
 patents
silverMedal2 out of 202 
 
Elan Pharmaceuticals, Inc.
 patents
bronzeMedal1 out of 35 
 
Athena Neurosciences, Inc.
 patents
4. 2 out of 834,601 
Other
 patents
where one patent can have more than one assignee

Years Active: 2000-2005

Loading Chart...
5 patents (USPTO):Explore Patents
1. 6888022 - Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis (2005-05-03),
2. 6861558 - Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis (2005-03-01),
3. 6262302 - N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2001-07-17),
4. 6191166 - Methods and compounds for inhibiting &bgr;-amyloid peptide release and/or its synthesis (2001-02-20),
5. 6153652 - N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical (2000-11-28),

Title: Clark Norman Eid: Innovator in Alzheimer's Disease Research

Introduction

Clark Norman Eid is a notable inventor based in Cheshire, CT (US). He has made significant contributions to the field of Alzheimer's disease research, holding a total of 5 patents. His work focuses on methods and compounds that inhibit the release and synthesis of β-amyloid peptides, which are crucial in the development of Alzheimer's disease.

Latest Patents

Eid's latest patents include innovative methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis. These compounds have potential utility in treating Alzheimer's disease. The patents also disclose pharmaceutical compositions that comprise these compounds, along with methods for treating Alzheimer's disease both prophylactically and therapeutically.

Career Highlights

Throughout his career, Clark Norman Eid has worked with prominent companies, including Eli Lilly and Company. His experience in the pharmaceutical industry has greatly influenced his research and development efforts in combating Alzheimer's disease.

Collaborations

Eid has collaborated with notable individuals in his field, including James E Audia and Lee H Latimer. These collaborations have contributed to the advancement of his research and the development of effective treatments for Alzheimer's disease.

Conclusion

Clark Norman Eid is a dedicated inventor whose work has the potential to make a significant impact on the treatment of Alzheimer's disease. His innovative patents and collaborations highlight his commitment to advancing medical research and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…